Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | ALPG | P10696 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | SHBG | P04278 | 1/20 | 0.31 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15657625 | 1.00 | CYP1A2 (0.44) | CYP1A2CA1CA9KMT2ACYP2C19 | |
| SCHEMBL175395 | 1.00 | CYP1A2 (0.44) | CYP1A2CA1CA9KMT2ACYP2C19 | |
| SCHEMBL15658072 | 1.00 | CYP1A2 (0.44) | CYP1A2CA1CA9KMT2ACYP2C19 | |
| SCHEMBL7460313 | 1.00 | CYP1A2 (0.44) | CYP1A2CA1CA9KMT2ACYP2C19 | |
| SCHEMBL24730989 | 1.00 | CYP1A2 (0.44) | CYP1A2CA1CA9KMT2ACYP2C19 | |
| SCHEMBL24729397 | 1.00 | CYP1A2 (0.44) | CYP1A2CA1CA9KMT2ACYP2C19 | |
| SCHEMBL3823582 | 1.00 | CYP1A2 (0.44) | CYP1A2CA1CA9KMT2ACYP2C19 | |
| SCHEMBL15657038 | 1.00 | CYP1A2 (0.44) | CYP1A2CA1CA9KMT2ACYP2C19 | |
| SCHEMBL6839262 | 1.00 | CYP1A2 (0.44) | CYP1A2CA1CA9KMT2ACYP2C19 | |
| SCHEMBL15660813 | 1.00 | CYP1A2 (0.44) | CYP1A2CA1CA9KMT2ACYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240287561-A1 | BIOSYNTHETIC PRODUCTION OF MACROCYCLIC MUSK LACTONES FROM FATTY ACIDS | CONAGEN INC. (US) | 2024-08-29 | — | — | US | disclosed |
| US-20230332071-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP. | 2023-10-19 | — | — | US | disclosed |
| US-20230332071-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP. | 2023-10-19 | — | — | US | disclosed |
| US-20230332071-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP. | 2023-10-19 | — | — | US | disclosed |
| US-20230323244-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230323244-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230323244-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | PHYTO TECH CORP (US) | 2023-10-12 | — | — | US | disclosed |
| US-11639483-B2 | Macrocyclic musk lactones and uses thereof | PHYTO TECH CORP. (US) | 2023-05-02 | — | — | US | disclosed |
| US-11639483-B2 | Macrocyclic musk lactones and uses thereof | PHYTO TECH CORP. (US) | 2023-05-02 | — | — | US | disclosed |
| US-11639483-B2 | Macrocyclic musk lactones and uses thereof | PHYTO TECH CORP. (US) | 2023-05-02 | — | — | US | disclosed |
| US-9738757-B2 | Composition and polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-20160222168-A1 | Composition and Polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-08-04 | — | — | US | disclosed |
| US-9334371-B2 | Composition and polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-05-10 | — | — | US | disclosed |
| EP-2735581-A1 | COMPOSITION AND POLYMER | Asahi Kasei Chemicals Corporation (JP) | 2014-05-28 | — | — | EP | disclosed |
| US-20140121293-A1 | Composition and Polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-05-01 | — | — | US | disclosed |
| EP-2376467-B1 | FRAGRANCE COMPOSITION | KAO CORP (JP) | 2014-03-12 | — | — | EP | disclosed |
| US-8338361-B2 | Fragrance composition | KAO CORPORATION (JP) | 2012-12-25 | — | — | US | disclosed |
| US-20110269664-A1 | FRAGRANCE COMPOSITION | KAO CORPORATION (JP) | 2011-11-03 | — | — | US | disclosed |
| EP-2376467-A1 | FRAGRANCE COMPOSITION | Kao Corporation (JP) | 2011-10-19 | — | — | EP | disclosed |
| WO-2010082684-A1 | FRAGRANCE COMPOSITION | KAO CORPORATION (JP) | 2010-07-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11639483-B2 | Macrocyclic musk lactones and uses thereof | MGLL, UGCG, DAGLA | CYP1A2 477/4885CA1 4782/4885CA9 4512/4885 |
| US-20240287561-A1 | BIOSYNTHETIC PRODUCTION OF MACROCYCLIC MUSK LACTONES FROM FATTY ACIDS | FASN, COASY, ACSL4 | CYP1A2 949/4885CA1 4027/4885CA9 3704/4885 |
| US-20230323244-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | MGLL, UGCG, DAGLA | CYP1A2 477/4885CA1 4782/4885CA9 4512/4885 |
| US-20110269664-A1 | FRAGRANCE COMPOSITION | MSI2, MUS81, EMC1 | CYP1A2 399/4885CA1 3770/4885CA9 2748/4885 |
| US-20230332071-A1 | MACROCYCLIC MUSK LACTONES AND USES THEREOF | MGLL, UGCG, DAGLA | CYP1A2 477/4885CA1 4782/4885CA9 4512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.